
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Applied Research Program, 2 Statistical Research Program, Division of Cancer Control and Population Sciences, 3 Epidemiology Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland; 4 Massachusetts General Hospital, Boston; and 5 University of Massachusetts Medical School, Worcester, Massachusetts
Requests for reprints: Nancy Potischman, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 4005 EPN, 6130 Executive Boulevard, Bethesda, MD 20892-7344. Phone: 301-594-6573; Fax: 301-435-3710. E-mail: potischn{at}mail.nih.gov
A variety of in utero factors have been associated with risk of adult cancers, particularly birth weight, toxemia, and gestational age. These factors are thought to reflect hormonal exposures during pregnancy. We hypothesized that the prenatal hormonal milieu may explain part of the variation in cancer rates across ethnic groups, for example, the higher incidence of breast cancer in the Caucasian compared with Hispanic women and the higher incidence of prostate and lower incidence of testicular cancers among African-Americans compared with Caucasians. We measured hormones in early pregnancy blood samples from three ethnic groups in a health care plan in Boston, MA. Mean levels of androstenedione, testosterone, estrone, and prolactin were significantly lower in Caucasian women compared with Hispanic women. Although not statistically significant, estradiol levels were lower in Caucasian compared with Hispanic or African-American women. Concentrations of androstenedione, testosterone, and progesterone were notably higher in African-American compared with Caucasian or Hispanic women. These data are consistent with hypotheses that in utero hormonal exposures may explain some of the ethnic group differences in cancer risk.
This article has been cited by other articles:
![]() |
R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Lummaa, J. E. Pettay, and A. F. Russell Male twins reduce fitness of female co-twins in humans PNAS, June 26, 2007; 104(26): 10915 - 10920. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferretti, A. Felici, and F. Cognetti Pregnancy Levels of Estrogen and Progesterone: The Double-Edged Sword Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 634 - 634. [Full Text] [PDF] |
||||
![]() |
S.-M. HO, Y.-K. LEUNG, and I. CHUNG Estrogens and Antiestrogens as Etiological Factors and Therapeutics for Prostate Cancer Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 177 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Arslan, A. Zeleniuch-Jacquotte, A. Lukanova, Y. Afanasyeva, J. Katz, M. Levitz, G. Del Priore, and P. Toniolo Effects of Parity on Pregnancy Hormonal Profiles Across Ethnic Groups with a Diverse Incidence of Breast Cancer. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2123 - 2130. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |